ResMed Trading Volume Drops 32.64% Ranking 412th in Market

On April 8, 2025, ResMed's trading volume was $314 million, down 32.64% from the previous day, ranking 412th in the day's stock market. ResMed Inc. (RMD) fell 3.97%.

ResMed Inc. has announced that it will be holding its annual general meeting on April 15, 2025. The meeting will be held virtually, allowing shareholders to participate from anywhere in the world. The company will discuss its financial performance for the fiscal year 2024 and elect new board members.

ResMed Inc. has also announced that it will be releasing its earnings report for the first quarter of 2025 on April 22, 2025. The company is expected to report strong earnings growth, driven by increased demand for its sleep and respiratory care products. Analysts are predicting that the company will report earnings per share of $1.50, up from $1.20 in the same period last year.

ResMed Inc. has also announced that it will be launching a new product line of sleep apnea devices. The new devices will feature advanced technology that allows for more accurate diagnosis and treatment of sleep apnea. The company is expecting the new product line to drive significant revenue growth in the coming years.